Price T Rowe Associates Inc Invitae Corp Transaction History

Price T Rowe Associates Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $1,573 - $2,697	3,746 Added 3.14%	123,069 $78,000
Q3 2023 Nov 14, 2023	SELL	$0.6 - $1.53 $38,418 - $97,967	-64,031 Reduced 34.92%	119,323 $73,000
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $45,816 - $71,125	-43,635 Reduced 19.22%	183,354 $208,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $66,589 - $151,490	55,491 Added 32.36%	226,989 $307,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $48,319 - $102,007	28,257 Added 19.73%	171,498 $319,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $27,977 - $127,076	-14,725 Reduced 9.32%	143,241 $353,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $132,464 - $560,331	-62,190 Reduced 28.25%	157,966 $385,000
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $10.7 Million - $26.5 Million	-1,697,392 Reduced 88.52%	220,156 $1.76 Million
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $8.4 Million - $16.4 Million	-571,320 Reduced 22.96%	1,917,548 $29.3 Million
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $109,322 - $151,099	-4,497 Reduced 0.18%	2,488,868 $70.8 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1 Million - $1.55 Million	-38,411 Reduced 1.52%	2,493,365 $84.1 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $13.9 Million - $23.9 Million	419,051 Added 19.83%	2,531,776 $96.7 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $82.6 Million - $121 Million	2,112,725 New	2,112,725 $88.3 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.